PD-L1 TPS is the recognised and approved scoring approach in NSCLC but only takes into account tumour cell expression, whilst PD-L1 imaging techniques, including [99mTc]NM-01 SPECT/CT, quantify PD-L1 expression in the entire tumour microenvironment. Here, CD274 is linked to non-small cell lung carcinoma.